Author(s)

Shen Shiheng, Yan Shaoxiong

Corresponding Author

Yan Shaoxiong

Abstract

Objective: to observe the medical treatment and efficacy of severe heart failure in the elderly. Methods: 84 elderly patients with severe heart failure from December 2017 to March 2019 were randomly selected from our hospital and randomly divided into Control Group (N 42) and Experimental Group (n 42). The Control Group was given conventional medical treatment,and the experimental group was given Metoprolol combined with Irbesartan hydrochlorothiazide treatment. The LVEF, Nyha and BNP indexes, clinical efficacy and recurrence were compared between the two groups. Results: There was no significant difference in LVEF, NYHA and BNP between the two groups before treatment (p > 0.05) . After treatment, LVEF, Nyha and BNP of the experimental group were better than those of the routine group (p < 0.05) . The total effective rate of the experimental group was 92.86% , which was much higher than that of the control group (p < 0.05) , and the recurrence rate of the experimental group was 4.76% , which was much lower than that of the routine group (p < 0.05) . Conclusion: Medical Treatment of metoprolol combined with Irbesartan and hydrochlorothiazide can effectively relieve the clinical symptoms of elderly patients with severe heart failure, reduce the recurrence rate and improve the therapeutic effect. It has the value of clinical popularization.

Keywords

Severe heart failure in the elderly; Internal medicine; Treatment